Table 3.
Treat time (min) | Ultrasound power (W) |
SE2 |
P-Values1 |
||||||
---|---|---|---|---|---|---|---|---|---|
0 | 100 | 300 | 500 | Power | Time | Time × Power | |||
Surface hydrophobicity (S0) | 0 | 1383.20ay | 1385.48ay | 1375.16az | 1357.25ax | 95.24 | <0.001 | <0.001 | <0.001 |
60 | 1499.52cx | 1681.74bx | 2056.57ax | 1487.41cx | |||||
120 | 1551.85bx | 1717.46ax | 1834.44ay | 1446.00bx | |||||
Particle size (μm) | 0 | 1790.0ax | 1792.5ax | 1746.67ax | 1750.0ax | 102.99 | <0.001 | <0.001 | <0.001 |
60 | 865.95ay | 615.65cy | 402.42dz | 747.32bz | |||||
120 | 817.73by | 344.14dz | 662.71cy | 1181.18ay | |||||
Solubility (%) | 0 | 31.92az | 32.31az | 33.09ay | 32.81ax | 3.33 | <0.001 | <0.001 | <0.001 |
60 | 37.61cy | 42.17by | 48.43ax | 27.14dx | |||||
120 | 43.29bx | 48.80abx | 52.22ax | 28.76cx |
3a ~ d in the same row indicate a significant difference between ultrasound power (P < 0.05).
4x ~ z in the same column indicate significant difference between treatment time (P < 0.05).
5indexes at the 0 min express the initial value of myofibrillar proteins before treatment.
P-Values indicate the level of significance including high-intensity ultrasound power, treatment time and their interaction.
SE: standard error.